Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia

Clinical Microbiology and Infection

Volumn 11, Issue 5, 2005, Pages 415-418

  Kang, C I ^a   Kim, S H ^a   Park, W B ^a   Lee, K D ^a   Kim, H B ^a   Kim, E C ^a,b   Oh, M D ^a,b   Choe, K W ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Bacteraemia; Community acquired; Pneumonia; Pseudomonas aeruginosa; Sepsis; Treatment outcome

Indexed keywords

AMIKACIN; AZITHROMYCIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; IMIPENEM; PIPERACILLIN; SULTAMICILLIN; TOBRAMYCIN;

ADULT; AGED; ARTICLE; BACTEREMIA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; INCIDENCE; MALE; MORTALITY; NEUTROPENIA; OUTCOMES RESEARCH; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; SOLID TUMOR;

EID: 17744372091     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01102.x     Document Type: Article

References (6)

1. Chatzinikolaou I, Abi-Said D, Bodey GP et al. Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes. Arch Intern Med 2000; 160: 501-509.
2. Vidal F, Mensa J, Almela M et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antimicrobial therapy: analysis of 189 episodes. Arch Intern Med 1996; 156: 2121-2126.
3. Hatchette TF, Gupta R, Marrie TJ. Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature. Clin Infect Dis 2000; 31: 1349-1356.
4. Huang YC, Lin TY, Wang CH. Community-acquired Pseudomonas aeruginosa sepsis in previously healthy infants and children: analysis of forty-three episodes. Pediatr Infect Dis J 2002; 21: 1049-1052.
5. Boffi El Amari E, Chamot E, Auckenthaler R, Pechere JC, Van Delden C. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis 2001; 33: 1859-1864.
6. Kang CI, Kim SH, Kim HB et al. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. Clin Infect Dis 2003; 37: 745-751.